Perforation in the bypassed stomach following laparoscopic Roux-en-Y gastric bypass.

Obes Surg

Minimally Invasive Surgical Program, West Penn Allegheny Health System, Pittsburgh, PA, USA.

Published: October 2003

Access to the bypassed stomach is difficult following laparoscopic Roux-en-Y gastric bypass (LRYGBP). The bypassed stomach is not readily available for endoscopic or radiographic evaluation. Diagnosis and treatment of peptic ulcer disease and its complications in the excluded stomach becomes difficult. We present a case of perforation in the bypassed stomach following LRYGBP secondary to peptic ulcer disease.

Download full-text PDF

Source
http://dx.doi.org/10.1381/096089203322509435DOI Listing

Publication Analysis

Top Keywords

bypassed stomach
16
perforation bypassed
8
laparoscopic roux-en-y
8
roux-en-y gastric
8
gastric bypass
8
stomach difficult
8
peptic ulcer
8
ulcer disease
8
stomach
5
stomach laparoscopic
4

Similar Publications

Roux-en-Y gastric bypass (RYGB) is a common surgical treatment for morbid obesity, but rare complications involving the excluded gastric remnant can pose significant challenges. A 65-year-old female with a history of RYGB presented with sudden onset of left upper quadrant abdominal pain, bloating, nausea, and loss of appetite. Laboratory tests revealed leukocytosis.

View Article and Find Full Text PDF

Esophageal Carcinoma Cuniculatum.

Ann Thorac Surg Short Rep

September 2024

Department of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

Esophageal carcinoma cuniculatum is a rare histology and can be difficult to diagnose prior to resection. To date, there have been 28 cases of resected esophageal carcinoma cuniculatum reported. Herein we describe a case found in the stomach of a patient who previously underwent a Roux-en-Y gastric bypass surgery.

View Article and Find Full Text PDF

Vitamin B, or pantothenate, forms the molecular "backbone" of coenzyme A (CoA), which is essential for more than a hundred biochemical reactions in humans. Genetic defects that disrupt the CoA pathway cause severe degenerative disorders that may be amenable to treatment with compounds that can bypass the metabolic block. The pantothenate metabolite, 4'-phosphopantetheine (4'PPT), can serve as an alternative substrate for cellular CoA synthesis and may therefore be an essential nutrient in managing disorders where pantothenate cannot meet all metabolic requirements.

View Article and Find Full Text PDF

Gastric remnant volvulus following Roux-en-Y gastric bypass (RYGB) surgery is rare, with only two previously reported cases. Herein, we present the first case of gastric remnant volvulus following gastric sleeve conversion to RYGB in a 32-year-old female. Management for gastric remnant volvulus has not been clearly described in the literature due to the rarity of cases; however, previously documented cases of gastric remnant volvulus following RYGB were managed with gastropexy or resection of the gastric remnant.

View Article and Find Full Text PDF
Article Synopsis
  • A 60s male patient diagnosed with advanced gastric cancer (with pyloric stenosis and enlarged lymph nodes) experienced significant tumor reduction after two courses of chemotherapy before surgery.
  • He underwent laparoscopic gastric jejunal bypass followed by distal gastrectomy and para-aortic lymph node dissection, with positive surgical results and no further tumor growth observed.
  • After the operation, he received a year of adjuvant chemotherapy and has remained recurrence-free for 1.5 years, highlighting the effectiveness of preoperative treatment for this condition.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!